Earnings Outlook For Mirum Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Mirum Pharmaceuticals (NASDAQ:MIRM) is set to release its latest quarterly earnings report on November 2, 2023. Analysts estimate an earnings per share (EPS) of $-0.65. The company's past performance shows a mixed trend of beating and missing EPS estimates, which has led to varied stock price changes. The company's shares were trading at $27.43 as of October 31, with a 22.87% increase over the last 52-week period.
November 01, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Mirum Pharmaceuticals is expected to report an EPS of $-0.65 in its upcoming earnings. The company's past performance shows a mixed trend of beating and missing EPS estimates, which has led to varied stock price changes.
The upcoming earnings report is a significant event for Mirum Pharmaceuticals. The company's past performance shows a mixed trend of beating and missing EPS estimates, which has led to varied stock price changes. However, it's uncertain how the market will react to the upcoming earnings, hence the neutral score.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100